In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response

Biomaterials

Volumn 21, Issue 1, 2000, Pages 89-96

  Lamba, Nina M K ^a   Courtney, James M ^a   Gaylor, John D S ^a   Lowe, Gordon D O ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cellulose; Complement activation; Contact activation; Heparin; Polyacrylonitrile; Polyvinylchloride

Indexed keywords

ACRYLONITRILE; BLOOD CLOTTING FACTOR 12; COMPLEMENT COMPONENT C3A; CUPROPHANE; HEPARIN; POLYMER; POLYVINYLCHLORIDE;

ANTICOAGULATION; ARTICLE; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; HEPARINIZATION; PLASMA; PRIORITY JOURNAL; TISSUE REACTION;

ACRYLIC RESINS; ACRYLONITRILE; ANTICOAGULANTS; ANTITHROMBIN III; BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; CELLULOSE; COMPLEMENT ACTIVATION; COMPLEMENT C3A; DIETHYLHEXYL PHTHALATE; FACTOR XII; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; PLASTICIZERS; POLYVINYL CHLORIDE;

EID: 0033990483     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(99)00145-3     Document Type: Article

References (45)

1. Craddock P.R., Fehr J., Dalmaso A.P., Brigham K.L., Jacob H.S. Haemodialysis leukopenia. pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes J Clin Inv. 59:1977;879.
2. Chenoweth D.E., Cheung A.K., Henderson L.W. Anaphylatoxin formation during haemodialysis. effects of different dialyzer membranes Kidney Int. 24:1983;764-769.
3. Ivanovich P., Chenoweth D.E., Schmidt R., Klinkmann H., Boxer L.A., Jacob H.S., Hammerschmidt D.E. Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int. 24:1983;758-763.
4. Blass CR. The application of plasticised polyvinyl chloride materials for the collection and delivery of blood and blood components. MPhil, University of Strathclyde.
5. Jones C. Blood response to plasticised poly(vinyl chloride). PhD, University of Strathclyde.
6. Branger B. Biocompatibility of blood tubings. Int J Artif Organs. 13:1990;697-703.
7. Courtney J.M., Irvine L., Jones C., Mosa S.M., Robertson L.M., Srivastava S. Biomaterials in medicine - a bioengineering perspective. Int J Artif Organs. 16:1993;164-171.
8. Lamba N.M.K., Gaylor J.D.S., Courtney J.M., Lowe G.D.O. Complement activation by cellulose: investigation of the effects of time, area, flow rate, shear rate and temperature on C3a generation in vitro, using a parallel plate flow system. J Mater Sci, Mater Med. 9:1998;409-414.
9. Janatova J., Cheung A.K., Parker C.J. Biomedical polymers differ in their ability to activate complement. Complement Inflammation. 8:1991;161-169.
10. Labarre D., Montdargent B., Carreno M.-P., Maillet F. Strategy for in vitro evaluation of the interaction between biomaterials and the complement system. J Appl Biomater. 4:1993;231-240.
11. Gallimore M.J., Rees W.A., Fuhrer G., Heller W. A direct chromogenic peptide substrate assay for Hageman Factor (FXII). Fibrinolysis. 1:1987;123-127.
12. Sundaram, S. Contact activation phase of blood coagulation during in vitro blood-biomaterials interactions and clinical investigations. PhD, University of Strathclyde.
13. Matata B.M., Wark S., Sundaram S., Courtney J.M., Gaylor J.D.S., Bowry S.K., Vienken J., Lowe G.D.O. In vitro contact phase activation with haemodialysis membranes. role of pharmaceutical agents Biomaterials. 166:1995;1305-1312.
14. Matata B.M., Courtney J.M., Sundaram S., Wark S., Bowry S.K., Vienken J., GD L. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII). its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes J Biomed Mater Res. 31:1996;63-70.
15. Matata B.M., Yin H.Q., Courtney J.M., Gaylor J.D.S., Lamba N.M.K., Lowe G.D.O., Suzuki K., Kimura H., Izumi K., Klinkmann H. In vitro blood compatibility evaluation of hollow fibre membrane using a controlled flow system. a comparative study Int J Artif Organs. 19:1996;582-589.
16. Ghebrehiwet B., Randazzo B.P., Dunn J.T., Silverberg M., Kaplan A.P. Mechanisms of activation of the classical pathway of complement by Hageman Factor. J Clin Inv. 71:1983;1450-1456.
17. Johnson RJ. Immunology and the complement system. Biomat Sci 1996:173-87.
18. Pangburn M.K., Muller-Eberhard H.J. Relation of a putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement. J Exp Med. 152:1980;1102-1114.
19. Kazatchkine M.D., Carreno M.P. Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials. 9:1988;30-35.
20. Payne M.S., Horbett T.A. Complement activation by hydroxyethylmethacrylate-ethylmethacrylate copolymers. J Biomed Mater Res. 21:1987;843-859.
21. Schaefer R.M., Rautenberg W., Neumann S., Heidland A., Hörl W.H. Improvement of dialyzer compatibility by reduction of membrane surface area. Clin Nephrol. 26:1986;535-538.
22. Vienken J., Baurmeister U. Improved biocompatibility of dialyzers by reduced membrane surface area. Artif Organs. 11:1987;272-273.
23. Goldman M., Lietaer N., Lambert P., Thayse C., Vanherweghem J.-L. Complement activation and leucopenia in cellulosic haemodialyzers; influence of the membrane area and role of hydroxyl moieties. Life Support Systems. 5:1987;317-322.
24. Mahiout A., Meinhold H., Kessel M., Schulze H., Baurmeister U. Dialyzer membranes. effect of surface area and chemical modification of cellulose on complement and platelet activation Artif Organs. 11:1987;149-154.
25. Mahiout A., Matata B.M., Vienken J., Courtney J.M. Ex vivo complement protein adsorption on positively and negatively charged cellulose dialyser membranes. J Mater Sci, Mater Med. 8:1997;287-296.
26. Hoenich N.A., Woffindin C., Stamp S., Roberts S.J., Turnbull J. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis? Biomaterials 1997;18:1299-303.
27. Cheung A.K., Parker C.J., Wilcox L.A., Janatova J. Activation of complement by haemodialysis membranes. polyacrylonitrile binds more C3a than Cuprophan Kidney Int. 37:1990;1055-1059.
28. Kim S.W., Peterson R.V., Lee E.S. Effect of phthalate plasticiser on blood compatibility of polyvinylchloride. J Pharm Sci. 65:1976;670-673.
29. Barbucci R, Magnani A. Surface infrared analysis of standard biomaterials. The reference materials of the European Communities; results of hemocompatibility tests. 1992. pp. 27-36.
30. Edens R.E., Linhardt R.J., Weiler J.M. Heparin is not just an anticoagulant anymore. six and one-half decades of studies on the ability of heparin to regulate complement activity Complement Today. Complement Profiles. 1:1993;96-120.
31. Takaoka T, Malchesky PS, Nose Y, Influence of heparin and citrate on complement activation in plasma exchange. Progr Artif Organs 1986;553-9.
32. Guma M, Ligouri C, DelosReyes M, Keil LB, Debari VA. The biphasic response of complement to heparin. ASAIO J 1994:57.
33. Kazatchkine M.D., Featon D.T., Silbert J.E., Austen K.F. Surface-associated heparin inhibits zymosan-induced activation of the human complement pathway by augmenting the regulator action of the control proteins on particle-bound C3b. J Exp Med. 150:1979;1202-1215.
34. Boackle R.J., Caughman G.B., Vesely J., Medgyesi G., Fudenberg Potentiation of Factor H by heparin. a rate-limiting mechanism for inhibition of the alternative complement pathway Mol Immunol. 20:1983;1157-1164.
35. Weiler J.M., Linhargt R.J. Antithrombin III regulates complement activity in vitro. J Immunol. 146:1991;3889-3894.
36. Maillet F., Petitou M., Choay J., Kazatchkine M.D. Structure-function relationships in the inhibitory effect of heparin on complement activation. independency of the anti-coagulant and anti-complementary sites on the heparin molecule Mol Immunol. 25:1988;917-923.
37. Yin HQ. Blood compatibility of poly(vinyl chloride) tubing: in vitro and ex vivo assessment. PhD, University of Strathclyde.
38. Robertson L.M., Courtney J.M., Irvine L., Jones C., Lowe G.D.O. Modification of the blood compatibility of haemodialysis membranes. Artif Organs. 14:1990;41-43.
39. Chenoweth D.E. Complement activation during haemodialysis; clinical observations, proposed mechanisms and theoretical implications. Artif Organs. 8:1984;281-287.
40. Falkenhagen D., Bosch T., Brown G.S., Schmidt B., Holtz M., Baurmeister U., Gurland H., Klinkmann H. A clinical study on different cellulosic dialysis membranes. Nephrol Dial Transplant. 2:1987;537-545.
41. Griffin J.H. The role of surface in the surface-dependent activation of Hageman Factor. Proc Natl Acad Sci, USA. 75:1978;1998.
42. Hojima Y., Cochrane C.G., Wiggins R.C., Austen K.F., Stevens R.L. In vitro activation of the contact (Hageman Factor) system of plasma by heparin and chondroitin sulphate. Blood. 6:1984;1453-1459.
43. Pixley R.A., Cassello A., Cadena RAdl, Kaufman N., Colman R.W. Effect of heparin on the activation of FXII and the contact system in plasma. Thromb Haemost. 66:1991;540-547.
44. Fuhrer G., Gallimore M.J., Heller W., Hoffmeister H.-E. FXII; Blut. 61:1990;258-266.
45. Colman R.W., Scott C.F., Pixley R.A., Cadena RAdl Effect of heparin on the inhibition of the contact system of enzymes. Ann NY Acad Sci. 556:1989;95-103.